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Severe chronic venous insufficiency (CVI) can be
highly debilitating, and successful treatment is
fraught with difficulty, patient noncompliance, and
recurrence, despite the initial success of the treat-
ment. Because there is no pharmacologic interven-
tion that is beneficial, surgical treatments have been
explored. The perforating veins became targets for
surgical therapy in the late 1930s,1 but it was the
development of endoscopic subfascial surgery in
German-speaking countries during the 1980s2,3 that
attracted surgeons in the 1990s to the use of this
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Purpose: The safety, feasibility, and early efficacy of subfascial endoscopic perforator surgery (SEPS)
for the treatment of chronic venous insufficiency were established in a preliminary report. The
long-term clinical outcome and the late complications after SEPS are as yet undetermined.
Methods: The North American Subfascial Endoscopic Perforator Surgery registry collected infor-
mation on 148 SEPS procedures that were performed in 17 centers in the United States and
Canada between August 1, 1993, and February 15, 1996. The data analysis in this study focused
on mid-term outcome in 146 patients.
Results: One hundred forty-six patients (79 men and 67 women; mean age, 56 years; range, 27 to
87 years) underwent SEPS. One hundred and one patients (69%) had active ulcers (class 6), and
21 (14%) had healed ulcers (class 5). One hundred and three patients (71%) underwent concomi-
tant venous procedures (stripping, 70; high ligation, 17; varicosity avulsion alone, 16). There were
no deaths or pulmonary embolisms. One deep venous thrombosis occurred at 2 months. The fol-
low-up periods averaged 24 months (range, 1 to 53 months). Cumulative ulcer healing at 1 year
was 88% (median time to healing, 54 days). Concomitant ablation of superficial reflux and lack of
deep venous obstruction predicted ulcer healing (P < .05). Clinical score improved from 8.93 to
3.98 at the last follow-up (P < .0001). Cumulative ulcer recurrence at 1 year was 16% and at 2
years was 28% (standard error, < 10%). Post-thrombotic limbs had a higher 2-year cumulative
recurrence rate (46%) than did those limbs with primary valvular incompetence (20%; P < .05).
Twenty-eight of the 122 patients (23%) who had class 5 or class 6 ulcers before surgery had an
active ulcer at the last follow-up examination.
Conclusions: The interruption of perforators with ablation of superficial reflux is effective in
decreasing the symptoms of chronic venous insufficiency and rapidly healing ulcers. Recurrence or
new ulcer development, however, is still significant, particularly in post-thrombotic limbs. The
reevaluation of the indications for SEPS is warranted because operations in patients without pre-
vious deep vein thrombosis are successful but operations in those patients with deep vein throm-
bosis are less successful. Operations on patients with deep vein occlusion have poor outcomes. (J
Vasc Surg 1999;29:489-502.)
489
From the Division of Vascular Surgery (Canton and Drs Gloviczki
and Rhodes) and the Department of Biostatistics (Harmsen
and Ilstrup), Mayo Clinic and Foundation; University of
California at San Diego; and Scripps Memorial Hospital (Dr
Bergan).
Presented at the Fifty-second Annual Meeting of The Society for
Vascular Surgery, San Diego, Calif, June 9–10, 1998.
Reprint requests: Peter Gloviczki, MD, Mayo Clinic, 200 First St
SW, Rochester, MN 55905.
Copyright © 1999 by The Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/99/$8.00 + 0 24/6/95911
technique in the treatment of severe chronic venous
disease.4-17 Some surgeons extended the operation
to the treatment of the less severe forms of venous
insufficiency.2-4
Enthusiasm for the minimally invasive procedure
caused Ruckley18 to call for a number of studies to
put the operation on a rational footing, saying “evi-
dence-based medicine has not so far been a strong
feature of phlebological practice.” Recognizing that
the registry mechanism could yield a great deal of
valuable information, we collected information from
surgeons in North America and constructed a pre-
liminary report from the North American Subfascial
Endoscopic Perforator Surgery (NASEPS) reg-
istry.11 Ultimately, data were collected on 148 pro-
cedures performed in 17 institutions in the United
States and Canada. There were no early deaths or
pulmonary embolisms, and deep vein thrombosis
developed in only one patient. Although the report
did establish that the operation was safe and feasible,
the long-term outcome could not be evaluated.
Special attention was paid, however, to wound com-
plications, and the observed 6% rate was thought to
be high but was distinctly lower than the rates in the
reports of wound complications reported with the
open technique.19 More recently, a randomized trial
from Holland proved that endoscopic division of
incompetent perforating veins not only was as effec-
tive as open surgical exploration but also led to sig-
nificantly fewer wound healing complications.12
These observations were validated with a nonran-
domized trial that compared 30 subfascial endo-
scopic perforator surgery (SEPS) procedures with
37 open Linton operations, which concluded that a
significantly lower morbidity rate and a shorter hos-
pital stay were possible when the endoscopic tech-
nique was used.13
The first report from the NASEPS registry
emphasized the importance of superficial reflux in
the causation of venous ulceration.11 This may have
been its most important contribution because the
management of superficial reflux can be accom-
plished with standard, well-accepted operative pro-
cedures. It is the perforator interruption that has
remained controversial. Perrin,20 in an editorial on
the subject, has paraphrased Shakespeare by saying,
“to ligate or not ligate, that is the question.” It may
be that the controversy regarding perforator inter-
ruption can only be resolved with a prospective, ran-
domized trial. Nevertheless, the registry experience
can provide valuable data on the cardinal end point
of efficacy—the prevention of ulcer recurrence.
Therefore, the goal of the present study was to eval-
uate the efficacy of the SEPS procedure in prevent-
ing the recurrence of venous ulcer in patients with
advanced CVI. A second objective was to identify
those patients who would benefit most from the
interruption of incompetent perforating veins and,
conversely, to identify those patients at highest risk
for ulcer recurrence. This report contains mid-term
clinical results of the same patient population report-
ed earlier in the North American registry.11
PATIENTS AND METHODS
The preliminary report of the NASEPS registry
collected information from 148 SEPS procedures
that were performed in 17 centers in the United
States and Canada between August 1, 1993, and
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Fig 1. Cumulative ulcer healing in 101 patients after subfascial endoscopic perforator surgery.
February 15, 1996. For the current report, sufficient
data for repeated analysis were available on 146
patients. Data on follow-up information were col-
lected on data sheets and were entered into a com-
puterized database. To objectively assess the outcome
and to define the severity of disease before surgery
and at the time of the last follow-up, we used the
updated clinical classification of CVI.21 The clinical
scoring of venous disease was determined as suggest-
ed by the Consensus Committee of the American
Venous Forum on Chronic Venous Disease.22
To estimate the probability of ulcer healing and
ulcer recurrence, the Kaplan-Meier method of sur-
vival analysis was used. Ulcer healing was calculated
in patients with class 6 (active) ulcers only, and
cumulative ulcer recurrence was calculated in
patients with class 5 (healed) ulcers and class 6 ulcers
in whom the ulcer completely healed after surgery.
The start point (day 0) for the time to recurrence in
patients with class 6 ulcers was the date of the initial
ulcer healing. Predictors of ulcer healing and ulcer
recurrence were assessed with the log-rank test. The
signed rank test was used to calculate the surgical
outcome scores. Statistical significance was con-
firmed if P was less than .05.
RESULTS
The 146 patients included 79 men and 67
women, with a mean age of 56 years and a range from
27 to 87 years. All the patients had advanced CVI—
101 patients had active (class 6) ulcers and 21 had
healed (class 5) ulcerations (Table I). The cause of
CVI was previous deep venous thrombosis (DVT) in
56 patients (38%). These patients either had evidence
of secondary changes in the deep veins on duplex
scanning or phlebography (thickening, obstruction,
partial recanalization, or valvular incompetence in
partially recanalized veins) or had a documented his-
tory of DVT. All the other patients were considered
to have primary valvular incompetence that involved
the superficial, perforator, or deep venous system. In
the latter group, we included two patients with con-
genital CVI. The pathophysiology of CVI was reflux
in 137 patients and reflux and obstruction in nine
patients. All the patients had the clinical diagnosis of
perforator incompetence, but imaging studies
(venography or duplex scanning) to document per-
forator reflux were performed in only 128 patients.
Incompetence of the superficial system was docu-
mented in 98 limbs (67%), and incompetence of the
deep veins was present in 105 limbs (72%).
Combined deep and superficial reflux was present in
73 patients (50%). Isolated perforator incompetence
was noted in only seven patients (5%).
The previous operations that were performed on
these limbs included saphenous stripping in 25
patients, with or without avulsion of varicosities. One
patient had undergone avulsion of the varicose veins
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Fig 2. Effects of deep venous obstruction and reflux alone on ulcer healing after subfascial
endoscopic perforator surgery in 101 limbs with class 6 ulcers. Dashed line represents standard
error of greater than 10%.
alone. Twelve patients had undergone previous perfo-
rator ligation, and three patients had undergone
popliteal vein valve reconstructions. The initial
NASEPS report further detailed risk factors, anatom-
ic distribution, type of venous disease, and the preop-
erative evaluation in these patients.11
All the patients underwent SEPS procedures with
a variety of endoscopic techniques.11,23 Fifty-seven
patients underwent SEPS alone (n = 41) or in com-
bination with avulsion of varicose veins (n = 16). The
remaining 89 patients (61%) underwent concomitant
operations, including stripping of the greater (n =
68) or lesser (n = 2) saphenous vein, high ligation (n
= 17), or split thickness skin grafts (n = 2).
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Table I. Classification of chronic venous disease in 146 patients
No. of patients   
No. of patients with data at last
with preoperative follow-up
Category data (%) examination (%)
Clinical classification (C) C0, no signs of venous disease — 3 (2)
C1, telangiectasia or reticular veins — 0 (0)
C2, varicose veins 1 (1) 2 (1)
C3, edema without skin changes 2 (1) 0 (0)
C4, skin changes ascribed to venous disease 
(eg, pigmentation, venous eczema,  21 (15) 19 (14)
lipodermatosclerosis)
C5, skin changes as defined previously  21 (15) 94 (64)
with healed ulceration
C6, skin changes as defined previously with  101 (69) 28 (19)
active ulceration
Etiologic classification (E) Primary 88 (61) —
Secondary 56 (38) —
Congenital 2 (1) —
Anatomic classification (A) Superficial 98 (67) —
Deep 105 (72) —
Perforator 146 (100) —
Pathophysiologic classification (P) Reflux 137 (93) —
Obstruction 6 (4) —
Both 3 (2) —
Fig 3. Cumulative ulcer recurrence in 106 patients after subfascial endoscopic perforator
surgery. All limbs with class 5 ulcers at the time of subfascial endoscopic perforator surgery and
limbs with class 6 ulcers that subsequently healed were included.
The perioperative complications were reported
previously and included no deaths or thromboem-
bolic complications within 30 days.11 Recurrent
DVT developed in one patient at 2 months after the
operation. The wound complication rate was 6%:
superficial thrombophlebitis occurred in 5 patients
(3%) and saphenous neuralgia in 10 (7%). Two
patients had significant late complications. These
complications included stroke and above-knee
amputation for underlying arterial disease in a 75-
year-old nursing-home patient and recurrent DVT,
ulcer recurrence, and sepsis with subsequent death
in another patient at 2.5 years after surgery. Three
additional deaths occurred from causes unrelated to
CVI.
Eleven patients underwent additional procedures
after the SEPS, including saphenous stripping in two
patients, skin grafting in four patients, sclerotherapy
in one patient, and additional venous procedures on
the deep or perforating veins in four patients. Of
these four patients, one underwent left iliac vein
stenting and two have undergone repeated perfora-
tor interruption, one of whom also underwent
popliteal reconstruction. The fourth patient under-
went reconstruction of the popliteal vein valve.
Clinical outcome. During a mean follow-up
period of 24 months (range, 1 to 53 months; medi-
an, 29 months), the signs and symptoms of chronic
venous disease improved significantly in most
patients, as measured by the clinical score.21 The
mean preoperative clinical score of 8.93 (range, 0 to
18) decreased to 3.98 (range, 0 to 14; P < .0001;
Table II) at the last follow-up. The clinical outcome
scale, similar to the one proposed by the updated
classification, was applied to 92 patients whose doc-
umented follow-up periods extended for a mini-
mum of 1 year (mean, 30 months; range, 13 to 53
months). Because data on ambulatory venous pres-
sure measurements and venous refill time were not
available, the patients were scored in the following
manner on the basis of clinical deterioration or
improvement alone: +3, asymptomatic; +2, moder-
ate improvement; +1, mild improvement; 0,
unchanged; –1, mild worsening; –2, significant
worsening; –3, marked worsening. Applying these
criteria, at the last follow-up examination, 32
patients (35%) were asymptomatic, 30 (33%) had
moderate improvement, 14 (15%) had mild
improvement, 8 (8.5%) were unchanged, and 8
(8.5%) had conditions that were worse than their
preoperative status. The mean clinical outcome
score of +1.74 (range, +3 to –3) shows a significant
overall improvement (P < .0001). The clinical
scores also improved significantly from 9.0 (range,
0 to 18) to 4.3 (range, 0 to 14; P < .0001) in this
subgroup.
Ulcer healing. One hundred and one of the 146
patients had an active ulcer at the time of the
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Fig 4. Ulcer recurrence on the basis of cause of chronic venous insufficiency. Dashed line rep-
resents standard error of greater than 10%.
surgery. All the ulcers but 16 (16%) healed after the
surgery (Fig 1). The median healing time was 54
days. Cumulative ulcer healing was 25% by 32 days
and 75% by 179 days. Cumulative ulcer healing by 1
year was 88%, and, by 2 years, it was 95% (standard
error, <10%). Of the 50 patients with class 5 or 6
ulcers and with post-thrombotic syndrome, 44 had
active ulceration. The median time to heal in these
patients was 64 days versus 43 days for the 57
patients with primary incompetence (P = .13). Of
the nine patients with a component of deep venous
obstruction, eight had active ulcers. The median
time to heal was 296 days as compared with 46 days
in the 53 limbs with reflux alone (Fig 2; P = .02).
Cumulative ulcer healing at 1 year was 90% in limbs
with reflux alone and 56% in those limbs with deep
venous obstruction. Of the 16 patients whose ulcers
never healed, 10 had post-thrombotic syndrome,
with obstruction of deep veins in four (median fol-
low-up period, 4.3 months). However, the presence
of deep venous reflux was not associated with
delayed ulcer healing.
Ulcer recurrence. Twenty-six ulcer recurrences
were noted—19 patients had class 6 ulcers and seven
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A
B
Fig 5. Effects of saphenous vein stripping in addition to subfascial endoscopic perforator
surgery on ulcer healing (A) and recurrence (B). Limbs with subfascial endoscopic perforator
surgery alone include 15 patients who underwent avulsion of varicosities in addition to sub-
fascial endoscopic perforator surgery. Ulcer healing improved in limbs that underwent subfas-
cial endoscopic perforator surgery with saphenous stripping (P < .01), and recurrence rates
were similar (P = NS). Dashed line represents standard error of greater than 10%.
patients had class 5 ulcers at the time of SEPS.
However, the ulcers in 14 patients had healed again
by the end of the observation period, which result-
ed in a total of 28 patients (23%) with active (class
6) ulcers at the time of the last follow-up examina-
tion (16 nonhealed ulcers and 12 recurrent ulcers).
Six patients have had multiple recurrences since
SEPS. Before surgery, 12 of the 26 patients had
ulcers that were greater than 2 cm and 16 had mul-
tiple ulcers per limb at any given time. The recur-
rences, however, were typically single ulcers (n =
21), and only four were greater than 2 cm.
Cumulative initial ulcer recurrence was calculat-
ed in 106 patients (preoperative class 5, n = 21; class
6: n = 85; Fig 3). The patients with post-thrombot-
ic syndrome had a greater rate of ulcer recurrence as
compared with those patients with primary valvular
incompetence (P < .05; Fig 4). Post-thrombotic
limbs had 1-year and 2-year cumulative ulcer recur-
rence rates of 17% and 46%, respectively. Limbs with
primary valvular incompetence had 1-year and 2-
year recurrence rates of 15% and 20%, respectively.
The number of limbs with obstruction and healed
ulcers (n = 5) were insufficient to comment on the
association with ulcer recurrence, but all nine limbs
with obstruction either recurred (n = 5) or never
healed (n = 4). Of the 101 limbs with reflux alone as
the underlying pathophysiology, neither the pres-
ence of deep venous reflux (n = 72), with or without
superficial reflux, nor the presence of popliteal or
tibial reflux (n = 61) was associated with an
increased risk of ulcer recurrence.
Degree of compliance with postoperative adjunc-
tive compression therapy was reported in 94
patients. Lack of compliance with compression ther-
apy was not associated with ulcer recurrence.
Patients who were poorly compliant (n = 22), defined
as the use of prescribed adjunctive medical therapy
less than 75% of the time, had a 2-year cumulative
ulcer recurrence rate of 27%, which was not different
from the 29% recurrence seen in the compliant pop-
ulation (n = 72).
The contribution of operative experience with
SEPS was analyzed. Although the median time to
ulcer healing was longer in the centers with fewer
than 10 operations (94 days vs 43 days; P = .051),
the rate of ulcer recurrence at 2 years was identical
(27% vs 27%; P = NS).
A subset of 30 patients underwent duplex scan-
ning at a mean period of 16 months after surgery
(range, 1 to 50 months), with the clinical follow-up
period averaging 24 months (range, 1 to 52 months).
New or persistent incompetent perforating veins were
documented in 11 limbs (37%), nine of which had
one or two incompetent perforators. One limb had
four incompetent perforators, and one limb with a
persistent nonhealing ulcer at 28 months had six
incompetent perforators identified. Incompetent per-
forators were shown in three of five limbs with either
ulcer recurrence (n = 4) or a nonhealing ulcer (n = 1)
and in eight of 25 limbs without ulcer recurrence (P
= NS). The dominant pathophysiology in all 30 limbs
studied was reflux without obstruction. Post-throm-
botic limbs had incompetent perforators identified in
five of 12 limbs studied. Six of the 18 limbs with
either a congenital or primary cause of CVI had at
least one incompetent perforator.
Limbs that undergo subfascial endoscopic
perforator surgery without ablation of saphe-
nous reflux. Fifty-seven patients have had either
SEPS without other concomitant procedures (n =
41) or SEPS combined only with avulsion of vari-
cosities (n = 16). Forty-five (79%) had active ulcers,
and five had healed ulcers. Previous saphenous strip-
ping had been performed in 11 patients.
Clinical score improved significantly from 9.8
(range, 2 to 18) to 4.7 (range, 0 to 14) at the last
follow-up examination (P < .0001). The clinical out-
come scale of +1.93 (range, –1 to +3) also con-
firmed a significant improvement (P < .0001).
Cumulative ulcer healing was 78% at 1 year and
88% at 2 years, which was significantly different from
the 96% 1-year healing rate in the 56 patients with
class 6 ulcers, who underwent SEPS together with
ablation of saphenous reflux (P < .01; Fig 5A). Eight
of the nine limbs with a component of deep vein
obstruction were in this SEPS-alone subgroup.
Cumulative ulcer recurrence in the 38 patients in
this subgroup who had either preoperative class 5
ulcers or ulcers that healed was 29% at 1 year and 45%
at 2 years. The cumulative recurrence rates in the 68
limbs that underwent SEPS with saphenous stripping
were 8% and 25% at 1 and 2 years (Fig 5B). The dif-
ference between these groups was not significant (P
= .17). Four of the 11 recurrences in the SEPS-alone
group were in limbs with deep venous obstruction.
DISCUSSION
This registry report highlights many of the diffi-
culties in dealing with the patient population with
severe CVI and its advanced manifestations of lipo-
dermatosclerosis and healed or active ulcerations.
Patients who are lost to follow-up examination, even
those with active ulcers, plague attempts at scientific
reporting. Nevertheless, this collection of data
brings out certain important points. Among these is
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the reemphasis that SEPS with ablation of superficial
reflux results in significant clinical improvement and
rapid ulcer healing in most patients. Eighty-four per-
cent of the ulcers healed at a median time of 54 days
after surgery. This is important because ulcers failed
to heal in 101 patients before surgery in spite of an
estimated 75% good-to-excellent compliance with
nonoperative care. The ulcer healing time in this
study was substantially shorter than the healing time
reported in most series after conservative care.24-30
Another important point is the observation that a
large number of patients with ulcers (two thirds in
this series) have superficial venous reflux. The treat-
ment of saphenous incompetence with conventional
surgical techniques is possible and contributes to
rapid ulcer healing and a marked amelioration of the
patient’s condition. A final point of importance was
that the ulcer healing was poor in patients who had
post-thrombotic syndrome and evidence of residual
deep venous occlusion. In four of nine patients with
deep venous occlusion, the ulcer failed to heal after
SEPS, and ulcer recurrence developed in the remain-
ing five patients.
The number of early complications after SEPS is
significantly less than the number after open perfo-
rator ligation, and, as mentioned before, this is sup-
ported by the 6% wound complication rate in our
study and by two recent studies from other institu-
tions.12,13 The rate of risk of late complications
related to this procedure is low. One recurrent DVT
occurred at 2 months in a patient with a known pro-
tein C deficiency with multiple previous deep vein
thromboses. Recurrent DVT, sepsis, and death that
occurred in another patient at 2.5 years after the
operation cannot be attributed to the operation but
in itself emphasizes the occasional severity of infect-
ed venous ulceration in elderly patients. One other
late complication in this series, an amputation, was
the result of underlying chronic arterial disease.
Although this complication occurred 27 months
after the operation, it brings up the importance of
the exclusion of severe underlying arterial occlusive
disease with ulceration. Chronic ischemia is a relative
contraindication for SEPS and for the occasional
patient with chronic ischemia, SEPS. It should be
performed without the use of a thigh tourniquet.
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Table II. Mean clinical scores before and after surgical treatment in 146 limbs
Mean Mean
Category Scoring system preoperative score postoperative score P
Pain 0, none 0.35 ± 0.05
1, moderate, not 1.07 ± 0.05 <.0001
necessitating analgesics
2, severe, necessitating
analgesics
Edema 0, none 0.93 ± 0.04 0.62 ± 0.05
1, mild/moderate <.0001
2, severe
Venous claudication 0, none
1, mild/moderate 0.15 ± 0.03 0.14 ± 0.08 NS
2, severe
Pigmentation 0, none 1.22 ± 0.04
1, localized 1.00 ± 0.04 0.003
2, extensive
Lipodermatosclerosis 0, none
1, localized 0.92 ± 0.06 0.71 ± 0.05 0.006
2, extensive
Ulcer size (largest ulcer) 0, none 1.19 ± 0.07 0.31 ± 0.05
1 <2-cm diameter <.0001
2 >2-cm diameter
Ulcer duration 0, none 1.29 ± 0.07
1 ≤ 3 months 0.39 ± 0.06 <.0001
2 ‡ 3 months
Ulcer recurrence 0, none 1.20 ± 0.08
1, once 0.27 ± 0.05 <.0001
2, more than once
Ulcer number 0, none 0.95 ± 0.08
1, single 0.30 ± 0.05 <.0001
2, multiple
Total mean clinical score 8.93 3.98
A valid end point of any treatment for advanced
chronic venous disease should be the prevention of
ulcer recurrence. Cumulative ulcer recurrence in this
report was 16% at 1 year after surgery and 28% at 2
years. The recurrence rate reported here is much
higher than the 7% early recurrence rate that was
reported earlier in this registry.11 Indeed, recurrence
or lack of healing is more prevalent in this report
than in any other SEPS series published from a sin-
gle institution.4-17 A more pessimistic view of the
results would be that the ulcer recurrence rate is
high in these patients. Criticism of the SEPS opera-
tion will point out that the results are not better
than those results reported for the open Linton and
Cockett procedures18,19,31-34 or that they are not
superior to those results obtained with conservative
care alone.24-30 Such criticism would ignore the
important information derived from this study. That
is, that patients with previous deep venous throm-
bosis, with persisting deep venous occlusion and
incompetence, are the ones who remain vulnerable
to recurrent ulceration and other manifestations of
CVI. Similar to the Mayo Clinic series,16 a signifi-
cantly higher ulcer recurrence rate after SEPS in the
post-thrombotic group was uncovered in the
NASEPS study as well. However, the clinical benefit
of the operation was evident even in patients with
persistent or recurrent ulcers. In addition to an
improvement in clinical scores, which to a great
extent was a result of rapid healing, ulcers at last fol-
low-up examination were seldom multiple and their
size was less than 2 cm in all but four patients.
Another important point derived from this study
was that SEPS resulted in a significant clinical
improvement in patients with nonthrombotic CVI.
This finding was even more obvious in the Mayo
Clinic series of 57 SEPS procedures, in which a 9%
rate for new or recurrent ulcers was reported but
none occurred in patients with primary valvular
incompetence.16
The NASEPS report included patients from 17
institutions. The operations often represented the
first experience in endoscopic venous surgery by
many surgeons. A lack of experience, combined with
a lack of routine preoperative and postoperative
duplex scan mapping of perforators,35 may explain
at least some of the failures. Pierik et al15 have found
a clear association between missed or recurrent per-
forators and ulcer recurrence.
The adverse effect of deep venous reflux on ulcer
recurrence after surgery remains likely. Zukovszky,36
reporting from Nicolaides’ laboratory, described
that the patients with more advanced CVI frequent-
ly have incompetence in both the perforating veins
and the deep venous system from the popliteal vein
distally. The importance of the popliteal venous
valve as a gatekeeper has been highlighted by sever-
al reports, including the paper from Edinburgh that
called attention to popliteal venous incompetence as
being associated with impaired ulcer healing and
poor prognosis after the standard Linton opera-
tion.31 However, in the NASEPS study, a clear asso-
ciation between popliteal vein incompetence and
ulcer recurrence could not be shown. These findings
are similar to those of Burnand et al.32,33
Hemodynamic improvement after SEPS remains
difficult to show, and the lack of such data remains a
valid criticism of this operation. However, this reg-
istry experience reflects daily practice in vascular
surgery, where preoperative imaging with duplex
scanning is gaining increasing acceptance, but prac-
tical information obtained from plethysmography in
most patients remains scant. Functional assessment,
however, must be an integral part of any planned
randomized study, and information obtained on
venous function should be correlated with clinical
outcome. This registry deserves criticism because of
the lack of objective duplex scanning or hemody-
namic data. However, the report of Rhodes et al37
on strain gauge plethysmographic studies represents
a first step in gathering information in this area.
Those authors confirmed improved calf muscle
pump function and reduced venous incompetence in
26 patients at 6 months after SEPS and ablation of
superficial reflux. However, the clinical observations
of the authors and the previous experience reported
by others34 failed to confirm significant functional
improvement in patients who were post-thrombotic.
Balanced against the somewhat sobering mid-
term results of this NASEPS report are those of con-
servative care. These results admit a rate of initial
treatment failure and recurrence that ranges from
54% to 69% in short-term studies of 1 to 3
years.24-30 The report by Mayberry et al24 has been
widely quoted and has been used to bolster the
argument for conservative care and patient compli-
ance. However, Raju et al38 have pointed out that
Mayberry et al24 subdivided their patients into com-
pliant and noncompliant groups. The so-called com-
pliant group had an ulcer recurrence rate of 29%, but
the noncompliant group had a 100% recurrence of
ulcer at 3 years. If one recalculated these data with-
out excluding patients from follow-up or fractionat-
ing those who had been followed, the recurrence
rate would be closer to 30% in the 1st year. This is in
line with all the other reports in the literature,
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including the registry series, in which 78% of the
ulcers treated were recurrences after the failure of
previous conservative management.
The present registry report emphasizes the con-
tribution of superficial venous incompetence in the
genesis of venous ulceration and that these patients
fare well after surgery. The unanswered question is
the place of perforator vein interruption in this pop-
ulation. As has been pointed out recently, perforator
veins, even with their normal function conveying
blood from superficial to deep veins, may enlarge in
the presence of superficial reflux and become incom-
petent.39
It remains to be shown whether ablation of the
superficial reflux alone in these patients will reverse
incompetence of the perforators. In patients with
combined, deep, and perforator vein incompetence
and in the rare patients with isolated perforator
incompetence, the interruption of the incompetent
perforating veins appears to be essential to decrease
ambulatory venous hypertension. However, a partial
answer on the importance of perforator interruption
is given by the University of Ulm study.40 Forty limbs
with severe CVI were treated with only saphenous
vein stripping and high ligation first. Perforating vein
interruption was performed only as a subsequent
procedure when pain, edema, or venous ulcers per-
sisted. Only one limb failed to improve, and 70% of
the persistent venous ulcers healed during a follow-
up period of 2 months.
This North American report on mid-term results
concludes that SEPS, performed frequently with
ablation of the superficial venous reflux, is effective in
decreasing the symptoms of CVI and contributes to
rapid ulcer healing. Still, a significant number of
patients either have ulcers that fail to heal or have
recurrence, particularly those patients with post-
thrombotic syndrome. However, recurrent disease
after surgery appears to be less severe in most patients
than before surgery. Because patients with persistent
post-thrombotic venous occlusion benefited least
from the operation, the surgical indications in this
group should be reexamined and deep venous recon-
struction should be reconsidered alone or in combi-
nation with SEPS. As surgical experience with SEPS
increases and postoperative duplex scan studies con-
firm the completeness of perforator interruption, a
further decrease in the recurrence of CVI will also
likely occur. Nevertheless, a prospective randomized
study to define the need for perforator interruption
and to prove benefit of any surgical treatment over
nonoperative management appears essential.
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Dr E. John Harris, Jr (Stanford, Calif). When subfas-
cial endoscopic perforator surgery, or SEPS, began to
attract increased attention in the 1990s, I wondered if the
initials did not stand for Surgery Escaping Proper Scrutiny.
Thankfully, today Dr Bergan and his associates return to
the Joint Annual Meeting with a 2-year follow-up from
their original study. Their initial report defined the safety
and feasibility of the SEPS procedure performed among
17 centers on 148 patients. The procedure was performed
in a mixture of patients, most of whom had active or
healed ulcers with reflux as a primary pathophysiology.
Unfortunately, as one often sees with registry data, all of
the patients entered did not have similar procedures or
similar preoperative evaluations. This early report showed
that SEPS procedures were safe—only three of 151
patients had the procedure aborted—and the early results
suggested improved ulcer healing rates.
This current presentation brings us the intermediate
term results of ulcer healing and recurrence in 146 of
these original patients. Cumulative ulcer healing was 88%
at 1 year, with a median time to healing of 54 days.
Cumulative recurrence rate was 16% at 1 year and 28% at
2 years. Although reflux was the primary pathophysiology
of venous disease in all patients, as many as 13% of the
patients had no objective venous imaging before their
surgery. In those patients in whom we did have preopera-
tive venography or duplex scanning, we are not provided
results regarding the severity of their reflux.
This brings me to my first question. Do you have any
data on the severity of reflux in those patients who under-
went imaging? Do the authors have any data on the loca-
tion of perforator incompetence? Were the incompetent
perforators paratibial Cockett perforators, or did your def-
inition of incompetent perforators include proximal medi-
al calf perforators or the perforators of the distal medial
thigh? Our own experience shows primary valvular reflux
most frequently occurs in the saphenous vein and the
proximal medial calf perforator and infrequently occurs in
the paratibial perforators.
We know that all the patients were assumed to have
perforator incompetence and that additionally 67% of the
patients had superficial system incompetence. Isolated
perforator incompetence was noted in only 5% of this
patient group. The association of reflux in the other sys-
tems influenced the results of the SEPS procedure.
Concomitant ablation of superficial reflux and lack of deep
venous obstruction were strong predictors of ulcer heal-
ing. A small subset of eight patients with deep venous
obstruction had the worst ulcer healing rates. Patients
with post-thrombotic deep venous insufficiency, even
without evidence of obstruction, had a 2-year ulcer recur-
rence rate—twice that of the patients with primary valvu-
lar incompetence. With a 2-year ulcer recurrence rate
approaching 50% in patients with the post-thrombotic
deep venous insufficiency, do the authors believe there is
any role for SEPS in these patients?
Ablation of superficial venous insufficiency was highly
predictive of successful wound healing with SEPS.
Unfortunately, we have no data on similar patients with
class 5 and 6 ulcers who had ablation of superficial venous
insufficiency without concomitant SEPS. Does the reg-
istry contain any data on patients treated with ablation of
superficial venous reflux alone, or does the author have
any experience he can share with us? It is hard to know the
effect of SEPS alone in the registry because a significant
number of these patients in the registry already had under-
gone previous surgery often on the saphenous and perfo-
rator systems. There was a small subset of patients with
isolated perforator incompetence. How did their ulcer
healing rate and ulcer recurrence rates compare with the
registry as a whole?
Further, a small subset of patients did undergo objec-
tive imaging at the completion of their procedures with a
mean follow-up period of 16 months. New or persistent
perforators were identified in 37% of these patients.
Interestingly, these perforators were equally identified
among patients with healed ulcers and patients with
unhealed ulcers. These data suggest to me that incompe-
tent perforators are not the critical problem in the devel-
opment of venous ulceration. Therefore, how do the
authors decide which perforators to divide? Does one
divide only those perforators with severe reflux or those
perforators with any reflux or all perforators seen with the
endoscope?
I enjoyed reading this thoughtful and well-organized
article kindly provided to me by Dr Gloviczki. I concur
with the authors’ conclusions that the reevaluation of the
indications for SEPS is warranted. With the increasing
availability of venous duplex scanning, I encourage the
registry to include an objective assessment of all sites of
valvular reflux in the preoperative and postoperative
assessment of their patients. I believe these data will fur-
ther define the role of SEPS, which I believe will fre-
quently necessitate concomitant ablation of superficial
venous reflux in patients with primary valvular incompe-
tence. I commend the registry for continuing the evalua-
tion of this new procedure, and I encourage continued
critical evaluation.
Dr John J. Bergan (La Jolla, Calif). Dr Harris, thank
you for your thoughtful look at a long manuscript. You
grasped all of the essential points well. You, for example,
pointed out that the patients do not undergo identical
operations. Of course, they all had the same objective.
That is, to interrupt perforating veins by whatever means.
Another difference was that some patients had ablation of
superficial reflux and some did not.
We felt at the beginning that the registry concept,
although not a randomized study, would collect informa-
tion that was useful, and this turns out to be exactly the
case. For example, we now know that superficial reflux is
a terribly important component.
Dr Harris asked, what about patients who had ablation
of superficial reflux for chronic venous insufficiency and
did not have perforator interruption? Those patients could
not be registered because this is a perforator surgery reg-
istry. However, personal experience by many surgeons
shows that when it is possible to rid the patient of super-
ficial reflux, which is proven to be a major cause of the
severe venous insufficiency, those patients do well. And if,
at a later date, the lipodermatosclerosis clears and one can
find varicosities leading to perforators in that area, a sec-
ond-stage procedure can be done. Or, now with our pres-
ent information, we would think perforator interruption is
definitely to be considered in every limb with severe
chronic venous insufficiency.
This leads to the question asked: which perforators
does one divide? We know that the retromalleolar perfora-
tor is difficult, if not impossible, to reach with our present
endoscopic equipment. So, it can be divided as a separate
operation, a separate stage, a separate procedure, but not
endoscopically.
The other perforators, at least a third of them, are
found in the intermuscular septum that divides the deep
posterior compartment from the superficial posterior
compartment. So, that septum must be divided in every
case. That is where the Cockett 2 and 3 perforators are
found.
Then, which ones does one leave behind? Well, one
does not leave any perforators behind. There is no ques-
tion about some being good perforators and some being
bad perforators. But that cannot be decided by our pres-
ent technology.
Dr Harris correctly asks: what about limbs with post-
thrombotic ulceration, should they be denied operation?
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At the present time, our experience teaches that they may
have recurrence of dermatitis, that they may have recur-
rence of a single ulcer, but that their management is infi-
nitely easier after the perforating vein is removed.
Interestingly, this study also reveals for the first time
that new perforating veins do occur after surgery. That will
have to be corroborated by other studies. But the recur-
rence of dermatitis, the recurrence of ulceration, is associ-
ated with perforating vein incompetence where there were
no perforating veins before surgery. 
So, there is much to be learned in this fascinating area
of venous disease. Dr Harris, thank you again for the
thoughtful commentary on our paper. 
Dr Frank T. Padberg, Jr (East Orange, NJ). Dr
Bergan, I would like to commend you and the remainder
of the authors for so beautifully illustrating the new CEAP
classification system and for using it to classify the severity
of your venous disease. You have given us some informa-
tion that suggests that these ulcers heal rapidly, but you
have not claimed that they heal more rapidly. I suspect you
have carefully avoided this, but I would like your com-
ment. On the basis of registry data, is 54 days to a mean
healing better than an expected standard? Can we establish
what that standard should be?
Secondly, Dr Harris brought to our attention a small
group that had isolated perforator operations and presum-
ably isolated perforator incompetence as the cause of their
chronic venous insufficiency. Do you have any evidence
that hemodynamics were improved in that specific subset?
And finally, in today’s report, the 36% of patients with
post-thrombotic disease had a worse outcome. The
abstract had initially stated that this was a nonsignificant
finding. Certainly, this will influence our decision-making.
Perhaps the registry can play a big role in the sense of
defining which patients with post-thrombotic disease will
be more likely to benefit from surgical intervention. 
Thank you.
Dr Bergan. Thank you, Dr Padberg. Actually, what the
registry helps us with is corroborating our own clinical
findings or perhaps refuting our own prejudices. In fact,
that has happened here. We thought the popliteal venous
reflux was an indicator for bad results after surgery, and
that was not shown by the registry. 
The CEAP classification to which you referred is defi-
nitely useful. We know what we are talking about, but it
has its flaws. Anybody who has tried to classify limbs using
the whole classification sees that there is much too much
detail. But it does contribute the gross clinical classifica-
tion and a scoring system that allows us to tell whether a
group of patients is improved or not. 
Do the ulcers heal more rapidly? The registry cannot
ascertain that at all. All that we can say is that the registry
results are better with regards to rapidity of healing than
the published reports.
I think Dr Padberg and we have had the same experi-
ence. For example, when we have a patient under our care
who has plateaued as far as healing goes, we take the
patient to surgery and the patient heals within the next 30
days. That is not a prospective, randomized study, but it
does not take much to convince the staff of the clinic that
this is not a bad procedure.
Isolated perforating veins do occur. You have had the
same experience we have. The patients who underwent
nothing but perforator interruption have had even huge
venous ulcers heal. But we do not know about the hemo-
dynamics. It is a difficult group to study both before and
after surgery with regard to hemodynamics. Dr Rhodes at
the Mayo Clinic had some evidence that the operation
does improve hemodynamics. Dr Murray of our group
here in San Diego also has shown this to some extent.
However, the finding of new perforating veins in an area
that was operated on is discouraging. We will have to learn
more about that. 
Dr Mark R. Nehler (Denver, Colo). I have a question
about the future. Apparently, one of every four patients
had a recurrence. What do you think is the role of elastic
compression stockings? Do you think that we should try
to correct deep venous hemodynamics and be more
aggressive toward superficial venous abnormalities and
then put people in compression? Is this a procedure we
should do on all patients with lipodermatosclerosis and an
ulcer before elastic compressions, to get the target ulcer
healed so that they can wear the compression easier after-
wards to prevent recurrence? What is your current belief as
to the role of elastic compression in your therapy? 
Dr Bergan. Dr Nehler asks a good question. That is,
should we correct superficial reflux before, after, or with
deep venous reflux? Our findings are that the deep venous
reflux disappears in 94% of the limbs in which superficial
operations are done in early cases.
The answer to your question regarding stockings later
on is that there is no doubt that these people have had
their hemodynamics improved by the deep venous reflux
being ablated. We find that about two thirds of the
patients who come back to our clinics do not wear the pre-
scribed stockings. Of course, this is San Diego.
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 3 Gloviczki et al 501
APPENDIX. PARTICIPATING CENTERS AND SURGEONS OF THE NORTH AMERICAN
SUBFASCIAL ENDOSCOPIC PERFORATOR SURGERY REGISTRY
Emory Clinic Atlanta, Ga Alan Lumsden, MD
Jobst Vascular Center Toledo, Ohio John P. Pigott, MD
Hugh G. Beebe, MD
Steven M. Dosick, MD
Steven S. Gale, MD
Michael G. Vitti, MD
Ralph C. Whalen, MD
Loma Linda Surgery Medical Group Loma Linda, Calif John J. Bergan, MD
Jeffrey L. Ballard, MD
Maimonides Medical Center Brooklyn, NY Enrico Ascer, MD
Mayo Clinic Rochester, Minn Peter Gloviczki, MD
Sunil S. Menawat, MD
Jeffrey M. Rhodes, MD
Medical College of Wisconsin Milwaukee, Wis Robert A. Cambria, MD
Mount Sinai Medical Center New York, NY Harry Schanzer, MD
Milan Skladany, MD
Naval Medical Center San Diego, Calif Jay Murray, MD
New England Medical Center Boston, Mass Thomas F. O’Donnell, MD
Mark Iafrati, MD
Pennsylvania Hospital Philadelphia, Pa Keith D. Calligaro, MD
Matthew J. Dougherty, MD
Scripps Memorial Hospital La Jolla, Calif John J. Bergan, MD
Straub Clinic & Hospital, Inc Honolulu, Hawaii Robert L. Kistner, MD
Bo G. Eklof, MD
Elna Masuda, MD
The Toronto Hospital, General Division Toronto, Ontario, Canada Peter Kalman, MD
Barry Rubin, MD
University of Nevada Reno, Nev Ralph G. DePalma, MD
University of Pittsburgh Pittsburgh, Pa Robert Y. Rhee, MD
University of Utah Salt Lake City, Utah Peter F. Lawrence, MD
Spencer W. Galt, MD
Douglas L. Jicka, MD
Washington University, School of Medicine St Louis, Mo Brian G. Rubin, MD
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